Market Overview

Haemonetics Corporation (NYSE: HAE)

92.02 -0.30 (-0.32%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:




Q2 2021
Pre-Market
EPS:
REV:
0.87
252.566M



Q1 2021
Pre-Market
EPS:
REV:




Q4 2020
Pre-Market
EPS:
REV:
0.61
249.295M
0.73
247.15M
0.69
238.492M
-5.48%
-3.5%
Q3 2020
Pre-Market
EPS:
REV:
0.63
247.356M
0.76
255.4M
0.94
258.97M
23.68%
1.4%
Q2 2020
Pre-Market
EPS:
REV:
0.56
241.581M
0.69
249.77M
0.87
252.566M
26.09%
1.12%
Q1 2020
Pre-Market
EPS:
REV:
0.59
229.347M
0.63
237.95M
0.81
238.451M
28.57%
0.21%
Q4 2019
Pre-Market
EPS:
REV:
0.43
233.552M
0.55
250.63M
0.61
249.295M
10.91%
-0.53%
Q3 2019
Pre-Market
EPS:
REV:
0.62
234.043M
0.59
250.13M
0.63
247.356M
6.78%
-1.11%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!